American Health Technology's patent pending framework provides automated analysis, location and quantification of cancerous diseases including cancer cell detection, tumor and nuclei quantification, markers, mitosis, morphologic differentiation, disease types and other rare events.

AHT is the only tool allowing for automated oncology analysis using standard stain, IHC staining, and FISH (Fluorescence in Situ Hybridization) for molecular cytogenetics testing, electronic measurement and quantification.

AHT can provide treatment baseline measurements and real-time, electronic and repeatable progress measurements. 

                     

For Leukemia, blood-borne disease automated analysis, quantification, and research, AHT provides full electronic leukocyte differentials, location of plasma, blast cells, and all stages of White Blood Cell development.